News & Updates

Dalbavancin shows promise for complicated SAB management

21 May 2024 by

Findings from the DOTS trial presented at ESCMID Global 2024 underpin the potential of dalbavancin, a long-acting lipoglycopeptide, for the management of complicated Staphylococcus (S.) aureus bacteraemia (SAB) without requiring long-term vascular access.

Dalbavancin shows promise for complicated SAB management

21 May 2024

Improving outcomes with a soluble guanylate cyclase stimulator in patients with worsening HF

21 May 2024 by

Although guideline-directed medical therapies (GDMTs) for heart failure (HF) with reduced ejection fraction (HFrEF) are effective in reducing risks of mortality and hospitalization for HF (HHF), the clinical burden of HF remains high. At a recent scientific symposium, Dr Yuya Matsue of Juntendo University Graduate School of Medicine in Japan discussed strategies of tackling worsening HF (WHF) to improve patient outcomes and presented a case study of vericiguat in HFrEF.

Improving outcomes with a soluble guanylate cyclase stimulator in patients with worsening HF

21 May 2024

Ultra-long-acting basal insulin optimizes diabetes management

21 May 2024 by

In an interview with MIMS Doctor, Dr Ka-Yuen Lock, Specialist in Endocrinology, Diabetes and Metabolism in Hong Kong, discussed management of diabetes mellitus (DM), including use of ultra-long-acting insulin, in optimizing glycaemic control. She also shared a case study illustrating improvements in glucose variability and patient’s satisfaction with insulin degludec (IDeg) in type 1 DM (T1DM).

Ultra-long-acting basal insulin optimizes diabetes management

21 May 2024

Ustekinumab shows therapeutic potential in chronic pouchitis

21 May 2024

About half of individuals with chronic pouchitis respond to ustekinumab, as shown in a prospective study.

Ustekinumab shows therapeutic potential in chronic pouchitis

21 May 2024

Preemies get a growth boost with prenatal steroids

20 May 2024 by

Administering corticosteroids during pregnancy leads to improved postnatal growth in infants born extremely or very preterm, as shown in a study.

Preemies get a growth boost with prenatal steroids

20 May 2024

Outpatient harm often due to adverse drug events

20 May 2024

Adverse drug events commonly occur in the outpatient setting and are often serious, a study has shown. In addition, adverse event (AE) rates are greater in older adults.

Outpatient harm often due to adverse drug events

20 May 2024

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

20 May 2024 by

Prophylactic interferon-alpha (IFN-α) administered intranasally slashed the incidence of COVID-19 by almost half in a cohort of cancer patients in the C-SMART study.

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

20 May 2024

Onvansertib plus chemo shows promise in KRAS-mutant metastatic colorectal cancer

20 May 2024

In the second-line treatment of patients with metastatic colorectal cancer harbouring KRAS mutation, onvansertib combined with FOLIFRI/bevacizumab demonstrates promising clinical activity while having a manageable safety profile, according to the results of a phase Ib study.

Onvansertib plus chemo shows promise in KRAS-mutant metastatic colorectal cancer

20 May 2024

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

19 May 2024

In people with rheumatic and musculoskeletal diseases (RMDs), inactivated COVID-19 vaccines prove safe and effective at lowering the risk of COVID-19–related pneumonia, as shown in a study from China.

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

19 May 2024

Plant-based alkaloid may help adults go vape-free

18 May 2024 by

The plant-based alkaloid cytisinicline, when coupled with behavioural support, shows promise in the treatment of e-cigarette users who seek to break the habit.

Plant-based alkaloid may help adults go vape-free

18 May 2024

News & Updates

Filter by Specialty:

Specialty:

Dalbavancin shows promise for complicated SAB management

Dalbavancin shows promise for complicated SAB management

Improving outcomes with a soluble guanylate cyclase stimulator in patients with worsening HF

Improving outcomes with a soluble guanylate cyclase stimulator in patients with worsening HF

Ultra-long-acting basal insulin optimizes diabetes management

Ultra-long-acting basal insulin optimizes diabetes management

Ustekinumab shows therapeutic potential in chronic pouchitis

Ustekinumab shows therapeutic potential in chronic pouchitis

Preemies get a growth boost with prenatal steroids

Preemies get a growth boost with prenatal steroids

Outpatient harm often due to adverse drug events

Outpatient harm often due to adverse drug events

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

Onvansertib plus chemo shows promise in KRAS-mutant metastatic colorectal cancer

Onvansertib plus chemo shows promise in KRAS-mutant metastatic colorectal cancer

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

Plant-based alkaloid may help adults go vape-free

Plant-based alkaloid may help adults go vape-free